Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin, among others. Its specialty chemicals products include benzene sulphonyl chloride and methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include itraconazole, fluconazole, dabigatran, ticagrelor, sitagliptin and alpha lipoic acid. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SPA.

Company Officers

Prakash Patil
Chairman of the Board, Chief Executive Officer, Managing Director, Executive Director
Adhish Patil
Chief Financial Officer, Chief Operating Officer
Rushikesh Deole
Compliance Officer, Company Secretary
Harshit Savla
Joint Managing Director, Executive Director
Rashesh Gogri
Managing Director, Executive Director
Uday Patil
Executive Director
Harit Pragji Shah
Executive Director